Axogen Inc Stock Performance
| AXGN Stock | USD 17.90 0.27 1.53% |
On a scale of 0 to 100, Axogen holds a performance score of 7. The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Axogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Axogen is expected to be smaller as well. Please check Axogen's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Axogen's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Axogen Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Axogen displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.53 | Five Day Return 3.23 | Year To Date Return 9.15 | Ten Year Return 432.74 | All Time Return 347.5 |
Last Split Factor 105:100 | Dividend Date 2010-02-12 | Ex Dividend Date 2010-01-27 | Last Split Date 1994-07-11 |
1 | Axogen stock soars to 52-week high, reaches 15.95 - Investing.com | 12/23/2024 |
2 | Insider Trading | 12/31/2024 |
3 | Disposition of 132 shares by Naor Nir of Axogen at 15.22 subject to Rule 16b-3 | 01/06/2025 |
4 | Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and ... | 02/03/2025 |
5 | Acquisition by Erick DeVinney of 2500 shares of Axogen subject to Rule 16b-3 | 02/14/2025 |
6 | AxoGen Q4 2024 Earnings Preview | 02/24/2025 |
7 | Axogen, Inc. To Host Analyst Investor Day on March 4th | 02/25/2025 |
8 | Axogen Inc Q4 2024 Earnings Call Highlights Strong Revenue Growth and Strategic Market ... | 02/26/2025 |
9 | FY2025 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald | 02/28/2025 |
10 | Disposition of 5000 shares by Wendell Amy Mcbride of Axogen at 20.02 subject to Rule 16b-3 | 03/03/2025 |
11 | Disposition of 8296 shares by Erick DeVinney of Axogen at 18.35 subject to Rule 16b-3 | 03/04/2025 |
12 | Cantor Fitzgerald Reaffirms Overweight Rating for AxoGen - Defense World | 03/07/2025 |
13 | AxoGens SWOT analysis nerve repair innovators stock poised for growth - Investing.com | 03/11/2025 |
14 | Disposition of 4003 shares by Jens Kemp of Axogen at 18.36 subject to Rule 16b-3 | 03/12/2025 |
15 | Connor Clark Lunn Investment Management Ltd. Decreases Stock Holdings in AxoGen, Inc. | 03/17/2025 |
| Begin Period Cash Flow | 37 M |
Axogen |
Axogen Relative Risk vs. Return Landscape
If you would invest 1,485 in Axogen Inc on December 19, 2024 and sell it today you would earn a total of 305.00 from holding Axogen Inc or generate 20.54% return on investment over 90 days. Axogen Inc is currently generating 0.3902% in daily expected returns and assumes 4.0843% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Axogen, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Axogen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axogen Inc, and traders can use it to determine the average amount a Axogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0955
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AXGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.08 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Axogen is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axogen by adding it to a well-diversified portfolio.
Axogen Fundamentals Growth
Axogen Stock prices reflect investors' perceptions of the future prospects and financial health of Axogen, and Axogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Axogen Stock performance.
| Return On Equity | -0.0999 | ||||
| Return On Asset | -0.0103 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 816.98 M | ||||
| Shares Outstanding | 44.34 M | ||||
| Price To Earning | (47.07) X | ||||
| Price To Book | 7.52 X | ||||
| Price To Sales | 4.17 X | ||||
| Revenue | 187.34 M | ||||
| Gross Profit | 141.98 M | ||||
| EBITDA | 6.08 M | ||||
| Net Income | (9.96 M) | ||||
| Cash And Equivalents | 58.03 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 68.69 M | ||||
| Debt To Equity | 0.71 % | ||||
| Current Ratio | 4.52 X | ||||
| Book Value Per Share | 2.35 X | ||||
| Cash Flow From Operations | 4.54 M | ||||
| Earnings Per Share | (0.23) X | ||||
| Market Capitalization | 781.78 M | ||||
| Total Asset | 203.73 M | ||||
| Retained Earnings | (291.26 M) | ||||
| Working Capital | 68.61 M | ||||
| Current Asset | 35.05 M | ||||
| Current Liabilities | 3.71 M | ||||
About Axogen Performance
By examining Axogen's fundamental ratios, stakeholders can obtain critical insights into Axogen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Axogen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 267.01 | 157.94 | |
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.10) | (0.10) |
Things to note about Axogen Inc performance evaluation
Checking the ongoing alerts about Axogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Axogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Axogen Inc had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 141.98 M. | |
| Latest headline from thelincolnianonline.com: Connor Clark Lunn Investment Management Ltd. Decreases Stock Holdings in AxoGen, Inc. |
- Analyzing Axogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Axogen's stock is overvalued or undervalued compared to its peers.
- Examining Axogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Axogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Axogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Axogen's stock. These opinions can provide insight into Axogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share | Quarterly Revenue Growth 0.151 | Return On Assets | Return On Equity |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.